Literature DB >> 34227880

Static Magnetic Fields Dampen Focused Ultrasound-mediated Blood-Brain Barrier Opening.

Yaoheng Yang1, Christopher Pham Pacia1, Dezhuang Ye1, Yimei Yue1, Chih-Yen Chien1, Hong Chen1.   

Abstract

Background Focused ultrasound combined with microbubbles has been used in clinical studies for blood-brain barrier (BBB) opening in conjunction with MRI. However, the impact of the static magnetic field generated by an MRI scanner on the BBB opening outcome has not been evaluated. Purpose To determine the relationship of the static magnetic field of an MRI scanner on focused ultrasound combined with microbubble-induced BBB opening. Materials and Methods Thirty wild-type mice were divided into four groups. Mice from different groups were sonicated with focused ultrasound in different static magnetic fields (approximately 0, 1.5, 3.0, and 4.7 T), with all other experimental parameters kept the same. Focused ultrasound sonication was performed after intravenous injection of microbubbles. Microbubble cavitation activity, the fundamental -physical mechanism underlying focused ultrasound BBB opening, was monitored with passive cavitation detection. After sonication, contrast-enhanced T1-weighted MRI was performed to assess BBB opening outcome. Intravenously injected Evans blue was used as a model agent to evaluate trans-BBB delivery efficiency. Results The microbubble cavitation dose decreased by an average of 2.1 dB at 1.5 T (P = .05), 2.9 dB at 3.0 T (P = .01), and 3.0 dB at 4.7 T (P = .01) compared with that outside the magnetic field (approximately 0 T). The static magnetic field of an MRI scanner decreased BBB opening volume in mice by 3.2-fold at 1.5 T (P < .001), 4.5-fold at 3.0 T (P < .001), and 11.6-fold at 4.7 T (P <.001) compared with mice treated outside the magnetic field. It also decreased Evans blue trans-BBB delivery 1.4-fold at 1.5 T (P = .009), 1.6-fold at 3.0 T (P < .001), and 1.9-fold at 4.7 T (P < .001). Conclusion Static magnetic fields dampened microbubble cavitation activity and decreased trans-blood-brain barrier (BBB) delivery by focused ultrasound combined with microbubble-induced BBB opening. © RSNA, 2021 An earlier incorrect version of this article appeared online. This article was corrected on July 8, 2021.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34227880      PMCID: PMC8409100          DOI: 10.1148/radiol.2021204441

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   29.146


  32 in total

1.  Effect of a magnetic field on sonoluminescence.

Authors:  K Yasui
Journal:  Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics       Date:  1999-08

2.  Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain.

Authors:  Hao-Li Liu; Mu-Yi Hua; Hung-Wei Yang; Chiung-Yin Huang; Po-Chun Chu; Jia-Shin Wu; I-Chou Tseng; Jiun-Jie Wang; Tzu-Chen Yen; Pin-Yuan Chen; Kuo-Chen Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

3.  Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index.

Authors:  Nathan McDannold; Natalia Vykhodtseva; Kullervo Hynynen
Journal:  Ultrasound Med Biol       Date:  2008-01-22       Impact factor: 2.998

4.  Noninvasive and localized neuronal delivery using short ultrasonic pulses and microbubbles.

Authors:  James J Choi; Kirsten Selert; Fotios Vlachos; Anna Wong; Elisa E Konofagou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

5.  MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits.

Authors:  Nathan McDannold; Natalia Vykhodtseva; Scott Raymond; Ferenc A Jolesz; Kullervo Hynynen
Journal:  Ultrasound Med Biol       Date:  2005-11       Impact factor: 2.998

6.  The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure.

Authors:  Hong Chen; Elisa E Konofagou
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-30       Impact factor: 6.200

7.  Clinical trial of blood-brain barrier disruption by pulsed ultrasound.

Authors:  Alexandre Carpentier; Michael Canney; Alexandre Vignot; Vincent Reina; Kevin Beccaria; Catherine Horodyckid; Carine Karachi; Delphine Leclercq; Cyril Lafon; Jean-Yves Chapelon; Laurent Capelle; Philippe Cornu; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Sci Transl Med       Date:  2016-06-15       Impact factor: 17.956

8.  Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.

Authors:  Manabu Kinoshita; Nathan McDannold; Ferenc A Jolesz; Kullervo Hynynen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-25       Impact factor: 11.205

9.  Neuronavigation-guided focused ultrasound (NaviFUS) for transcranial blood-brain barrier opening in recurrent glioblastoma patients: clinical trial protocol.

Authors:  Ko-Ting Chen; Ya-Jui Lin; Wen-Yen Chai; Chia-Jung Lin; Pin-Yuan Chen; Chiung-Yin Huang; John S Kuo; Hao-Li Liu; Kuo-Chen Wei
Journal:  Ann Transl Med       Date:  2020-06

10.  Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound.

Authors:  Nir Lipsman; Ying Meng; Allison J Bethune; Yuexi Huang; Benjamin Lam; Mario Masellis; Nathan Herrmann; Chinthaka Heyn; Isabelle Aubert; Alexandre Boutet; Gwenn S Smith; Kullervo Hynynen; Sandra E Black
Journal:  Nat Commun       Date:  2018-07-25       Impact factor: 14.919

View more
  2 in total

1.  An Affordable and Easy-to-Use Focused Ultrasound Device for Noninvasive and High Precision Drug Delivery to the Mouse Brain.

Authors:  Zhongtao Hu; Si Chen; Yaoheng Yang; Yan Gong; Hong Chen
Journal:  IEEE Trans Biomed Eng       Date:  2022-08-19       Impact factor: 4.756

2.  Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA.

Authors:  Christopher P Pacia; Jinyun Yuan; Yimei Yue; Lu Xu; Arash Nazeri; Rupen Desai; H Michael Gach; Xiaowei Wang; Michael R Talcott; Aadel A Chaudhuri; Gavin P Dunn; Eric C Leuthardt; Hong Chen
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.